In-Stent Restenosis. ISR is the reduction of the lumen size as a result of neointimal hyperplasia (NH), an excessive growth of tissue inside the stented vessel.
由 MS Lee 著作 · 2016 · 被引用 63 次 — In-stent restenosis (ISR) is the narrowing of a stented coronary artery lesion. The mean time from percutaneous coronary intervention (PCI) to ISR was 12 ...
2022年7月20日 — In-stent restenosis is a blockage or narrowing that comes back in the portion of the coronary artery previously treated with a stent. What are ...
由 DJ Omeh 著作 · 2022 · 被引用 28 次 — Restenosis is the reduction in the diameter of the vessel lumen after angioplasty. Despite advances in stent technology, restenosis continues to be the most ...
由 E Shlofmitz 著作 · 2019 · 被引用 213 次 — ISR has classically been defined as a luminal narrowing with >50% diameter stenosis of a stented coronary segment or within 5 mm of a stent edge ...
由 F Alfonso 著作 · 被引用 40 次 — In-stent restenosis (ISR) is characterised by a significant reduction in the luminal diameter within the stented segment after a successful percutaneous ...
In-Stent Restenosis. ISR is the reduction of the lumen size as a result of neointimal hyperplasia (NH), an excessive growth of tissue inside the stented vessel.
由 G Giustino 著作 · 2022 · 被引用 81 次 — Repeated DES implantation is the most effective treatment for DES-ISR and should be preferred to improve long-term patency of restenotic lesions ...
